Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
VisiJet pleased as global sales top $600,000
Irvine, CA-Worldwide sales of VisiJet Inc.'s Epi-Tome and LasiTome products topped $600,000 through marketing agreements with Gebauer Medizintechnik GmbH of Neuhausen, Germany.
Irvine, CA-Worldwide sales of VisiJet Inc.'s Epi-Tome and LasiTome products topped $600,000 through marketing agreements with Gebauer Medizintechnik GmbH of Neuhausen, Germany.
VisiJet is seeking FDA approval to sell the products in the United States and has filed a 510(k) statement with the agency.
Related Videos
Related Content
